Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuan-Ching Chang

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Acta Oto-Laryngologica|July 9, 2008
Comparison of radiotherapy strategies for locally advanced hypopharyngeal cancer after resection and ileocolic flap reconstructionHung-Chi Tai, Chen-Hsi Hsieh, K S Clifford Chao, et al.
Breast Cancer Research and Treatment|February 9, 2022
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trialTamas Hickish, Ajay Mehta, Mei-Ching Liu, et al.
Journal of Nanobiotechnology|February 20, 2016
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexYu-Ling Lin, Chia-Hung Chen, Hsin-Yi Wu, et al.
BMC Cancer|September 14, 2023
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)Sung-Hsin Kuo, Ling-Ming Tseng, Shou-Tung Chen, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancerPo-Sheng Yang, Yi-Hsuan Lee, Chi-Feng Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2022
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 TrialJens Huober, Carlos H Barrios, Naoki Niikura, et al.
Journal of Nanobiotechnology|February 8, 2019
Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodiesYu-Ling Lin, Nu-Man Tsai, Chia-Hung Chen, et al.
Biological Procedures Online|May 11, 2018
Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric CancerYu-Chang Chuang, Hsin-Yi Wu, Yu-Ling Lin, et al.
Breast Cancer Research and Treatment|March 17, 2021
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXESYoung-Hyuck Im, Bulent Karabulut, Keun Seok Lee, et al.
Scientific Reports|February 16, 2016
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerI-Chun Chen, Yuan-Ching Chang, Yen-Shen Lu, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Acta Oto-Laryngologica|July 9, 2008
Comparison of radiotherapy strategies for locally advanced hypopharyngeal cancer after resection and ileocolic flap reconstructionHung-Chi Tai, Chen-Hsi Hsieh, K S Clifford Chao, et al.
Breast Cancer Research and Treatment|February 9, 2022
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trialTamas Hickish, Ajay Mehta, Mei-Ching Liu, et al.
Journal of Nanobiotechnology|February 20, 2016
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexYu-Ling Lin, Chia-Hung Chen, Hsin-Yi Wu, et al.
BMC Cancer|September 14, 2023
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)Sung-Hsin Kuo, Ling-Ming Tseng, Shou-Tung Chen, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancerPo-Sheng Yang, Yi-Hsuan Lee, Chi-Feng Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2022
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 TrialJens Huober, Carlos H Barrios, Naoki Niikura, et al.
Journal of Nanobiotechnology|February 8, 2019
Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodiesYu-Ling Lin, Nu-Man Tsai, Chia-Hung Chen, et al.
Biological Procedures Online|May 11, 2018
Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric CancerYu-Chang Chuang, Hsin-Yi Wu, Yu-Ling Lin, et al.
Breast Cancer Research and Treatment|March 17, 2021
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXESYoung-Hyuck Im, Bulent Karabulut, Keun Seok Lee, et al.
Scientific Reports|February 16, 2016
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerI-Chun Chen, Yuan-Ching Chang, Yen-Shen Lu, et al.
Pageof 8